ADIPOQ and obesity disorder: Future studies could benefit from the integration of additional obesity‐related biomarkers, such as lipid profiles, fasting glucose, inflammatory markers (e.g., C‐reactive protein, interleukin‐6), and adipokines (e.g., leptin, adiponectin).